 |
Chromaffin cells Transfection Reagent |
|
|
Catalog # 1733 - 0.5 mL $ 104.00
Catalog # 1734 - 1.5 mL $ 285.00
Transfection reagent for Chromaffin cells
- Kit includes Transfection Enhancer reagent and recommended transfection protocols
- Protocols provided for transfection of siRNA, DNA, mRNA and microRNA
- High cell viability
- Suitable for siRNA/DNA cotransfection
- Compatible with transfection in any plate format
- Reproducible results
- Minimal off-target effect
- Developed and manufactured by Altogen Biosystems
Transfection Efficiency:
Reagent exhibits at least 75% transfection
efficiency of siRNA delivery. Transfection efficiency
was determined by real-time RT-PCR.
Transfection Protocol:
Transfection protocols are provided with
the purchase of the reagent.
|
 |
DATA |
|
Figure 1. Cyclophilin B silencing efficiency was determined by qRT-PCR in the cells transfected by Cyclophilin B siRNA or non-silencing siRNA control following the recommended transfection protocol. Cyclophilin mRNA expression levels were measured 48 hours post-transfection. 18S rRNA levels were used to normalize the Cyclophilin B data. Values are normalized to untreated sample. Data are presented as means ± SD (n=3).
 |
Cancer Cell Lines and Primary Cells |
|
Primary cell cultures are used in biological and gene therapy studies and serve as important model systems that may more accurately represent the biology of normal cells. Many cultured cell lines, as well as the majority of primary cell cultures are able to be transfected with exogenous nucleic acids when appropriate transfection approaches are employed. Since the majority of transfection methods causes significant toxicity in primary cell cultures, optimizing this procedure, specifically the protocol and reagents to be utilized, is essential for developing an effective transfection strategies for a given cell type. ALTOGENŽ Kits for primary cells and sensitive cell lines have been designed to have significantly lower cytotoxicity than classical alternatives.
 |
Transfection Resource |
|
siRNA Transfection || Transfection Methods || Stable Transfection || RNAi || siRNA Library Screening || RNAi Therapeutics || Cell Transfection || In Vivo Transfection Reagents || Cell Line Specific Transfection Reagents
 |
Featured Products |
|
In Vivo Transfection Reagents || Fibroblast Cells Transfection Reagent || Astrocyte Cells Transfection Reagent || HEK-293 Transfection Reagent || MEF Transfection Reagent || HepG2 Transfection Reagent || CHO Reagent || MDA-MB Transfection Reagent || Cos7 Transfection Reagent || A549 Transfection Reagent || NIH3T3 Reagent || HUVEC Transfection Reagent || LNCaP Transfection Reagent || MCF-7 Reagent || PC-12 Reagent
 |
Altogen Research Services |
|
Altogen Custom Services provide specialized biotechnology and pharmaceutical services, including - generation of stable cell lines, RNA Interference (RNAi) services, assay development, screening and transfection services. Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Altogen Services offers generation of stable cell lines by transforming the cell line of choice to stably express gene of interest or shRNA-encoding construct. Cloning and shRNA expression services are available.
|